Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
CVS Health Corp (CVS)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: CVS (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -42.29% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 2.0 | Stock Returns Performance 1.0 |
Profits based on simulation | Last Close 01/14/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 64.83B USD | Price to earnings Ratio 12.18 | 1Y Target Price 64.94 |
Price to earnings Ratio 12.18 | 1Y Target Price 64.94 | ||
Volume (30-day avg) 14947699 | Beta 0.54 | 52 Weeks Range 43.56 - 78.21 | Updated Date 01/14/2025 |
52 Weeks Range 43.56 - 78.21 | Updated Date 01/14/2025 | ||
Dividends yield (FY) 5.54% | Basic EPS (TTM) 4.23 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 1.37% | Operating Margin (TTM) 1.59% |
Management Effectiveness
Return on Assets (TTM) 2.37% | Return on Equity (TTM) 6.7% |
Valuation
Trailing PE 12.18 | Forward PE 8.2 | Enterprise Value 137857161870 | Price to Sales(TTM) 0.18 |
Enterprise Value 137857161870 | Price to Sales(TTM) 0.18 | ||
Enterprise Value to Revenue 0.37 | Enterprise Value to EBITDA 9.71 | Shares Outstanding 1258409984 | Shares Floating 1255563644 |
Shares Outstanding 1258409984 | Shares Floating 1255563644 | ||
Percent Insiders 0.13 | Percent Institutions 82.68 |
AI Summary
CVS Health Corp (CVS) Overview
Company Profile:
History and Background: Founded in 1963 as a single store in Lowell, Massachusetts, CVS Health Corporation has evolved into a Fortune 5 company offering a wide range of healthcare services. Initially operating as a drugstore chain, CVS acquired Aetna in 2018, expanding its reach into the health insurance market.
Core Business Areas:
- Pharmacy Services: CVS operates over 9,000 retail pharmacies across the US, offering prescription dispensing, immunizations, and health consultations.
- Health Insurance: Through Aetna, CVS provides healthcare plans to individuals, employers, and government programs.
- Retail: CVS stores offer a wide range of products, including over-the-counter medications, health and beauty products, and convenience items.
- Specialty Pharmacy: CVS Specialty provides medications for complex and chronic conditions, including HIV/AIDS, oncology, and rheumatoid arthritis.
- PBM Services: CVS Caremark is a pharmacy benefit manager (PBM) that negotiates drug prices and manages pharmacy benefits for clients.
Leadership Team and Corporate Structure: Karen S. Lynch serves as President and CEO, leading a team of experienced executives across various business segments. The company operates a decentralized structure with individual business units responsible for their operations.
Top Products and Market Share:
- MinuteClinic: CVS operates over 1,100 MinuteClinics, offering convenient and affordable walk-in healthcare services.
- CVS Health Brand: The company offers a range of private-label products, including over-the-counter medications, vitamins, and personal care items.
- Aetna Medicare Advantage Plans: CVS offers a variety of Medicare Advantage plans, providing seniors with comprehensive healthcare coverage.
Market Share:
- Pharmacy Services: CVS has the largest pharmacy market share in the US, with approximately 28%.
- Health Insurance: Aetna ranks as the third-largest health insurance provider in the US, with a market share of approximately 12%.
- PBM Services: CVS Caremark is the largest PBM in the US, managing pharmacy benefits for over 100 million members.
Total Addressable Market:
- US Pharmacy Market: Estimated at $450 billion in 2023.
- US Health Insurance Market: Estimated at $1.5 trillion in 2023.
Financial Performance:
- Revenue: $324.5 billion in 2022.
- Net Income: $7.7 billion in 2022.
- Profit Margin: 2.4% in 2022.
- Earnings per Share (EPS): $8.77 in 2022.
Financial Performance Comparison: CVS has experienced steady revenue growth over the past five years, with net income fluctuating due to various factors, including acquisitions and investments.
Cash Flow and Balance Sheet: CVS maintains a strong cash flow position and a healthy balance sheet, with a debt-to-equity ratio of 0.65.
Dividends and Shareholder Returns:
- Dividend History: CVS has a history of paying dividends, with a current dividend yield of around 1.5%.
- Shareholder Returns: CVS stock has provided shareholders with a total return of over 50% in the past five years.
Growth Trajectory:
- Historical Growth: CVS has experienced consistent revenue growth over the past five years, driven by acquisitions and organic growth.
- Future Growth: The company expects continued growth in its pharmacy services and health insurance segments, fueled by an aging population and increasing demand for healthcare services.
Market Dynamics:
- Industry Trends: The healthcare industry is undergoing significant changes, including the rise of digital health and value-based care models.
- Demand-Supply Scenario: The demand for healthcare services is expected to continue to grow, driven by an aging population and rising chronic disease rates.
- Technological Advancements: Technology is playing an increasingly important role in healthcare, with CVS investing in areas such as telehealth and artificial intelligence.
Market Positioning: CVS is well-positioned to benefit from these trends, with its diversified business model and investments in technology and innovation.
Competitors:
- Pharmacy Services: Walgreens Boots Alliance (WBA), Rite Aid (RAD)
- Health Insurance: UnitedHealth Group (UNH), Anthem (ANTM)
- PBM Services: Express Scripts (ESRX), OptumRx
Competitive Advantages:
- Strong Brand Recognition: CVS has a strong brand reputation and customer loyalty.
- Large Pharmacy Network: CVS has the largest pharmacy network in the US, providing convenient access to healthcare services.
- Diversified Business Model: CVS's diversified business model provides stability and growth opportunities.
Potential Challenges and Opportunities:
Challenges:
- Competition: CVS faces intense competition from other pharmacy retailers and health insurance providers.
- Regulatory Changes: The healthcare industry is subject to constant regulatory changes, which can impact CVS's operations.
- Rising Healthcare Costs: The rising cost of healthcare is a concern for CVS and its customers.
Opportunities:
- Growing Demand for Healthcare Services: The aging population and rising chronic disease rates are creating a growing demand for healthcare services.
- Expansion into New Markets: CVS is exploring opportunities to expand into new markets, such as urgent care and home healthcare.
- Digital Health: CVS is investing in digital health solutions to improve patient care and access to healthcare services.
Recent Acquisitions:
- Signify Health (2023): This acquisition expands CVS's presence in the home health market, providing additional services to patients.
- Oak Street Health (2022): This acquisition strengthens CVS's primary care offerings, providing patients with more convenient access to healthcare services.
- Aetna (2018): This transformative acquisition expanded CVS's reach into the health insurance market.
AI-Based Fundamental Rating:
Rating: 8/10
Justification: CVS Health Corp. possesses a strong financial foundation, a dominant market position, and promising growth prospects. The company's diversification, investments in technology, and focus on value-based care position it well for future success. However, competitive pressures and rising healthcare costs remain potential challenges.
Sources:
- CVS Health Corp. Annual Report 2022
- CVS Health Corp. Investor Relations website
- Statista
- SEC filings
Disclaimer: This information is for educational purposes only and should not be considered investment advice. Please consult with a financial professional before making any investment decisions.
About NVIDIA Corporation
Exchange NYSE | Headquaters Woonsocket, RI, United States | ||
IPO Launch date 1984-12-17 | President, CEO & Director Mr. J. David Joyner CEBS | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 219000 | Website https://www.cvshealth.com |
Full time employees 219000 | Website https://www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.